MedTrace Logo

Dietary Fat, Eicosanoids and Breast Cancer Risk

NCT01824498 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2018-08-31

Study results available
· View outcomes & findings →

Summary

The primary objective of this investigation is to determine whether diets designed to increase plasma n3 concentrations (a low fat diet, with or without n3 fatty acid enrichment), will favorably affect sex hormone distribution in women in a direction associated with reduced risk of sex hormone-mediated cancer development. Specifically, we hypothesize that an increased concentration of circulating n3 fatty acids will reduce the biochemical markers associated with increased risk for developing certain sex hormone mediated cancers such as breast cancer

Conditions

Interventions

OTHER

Low Fat diet

Low fat diet = 20% fat

OTHER

Low Fat high n3 diet

Low Fat high n3 diet = 20% fat + 3% n3

OTHER

High Fat Diet

High Fat Diet = 40% fat

Sponsors & Collaborators

  • USDA Grand Forks Human Nutrition Research Center

    lead FED

Principal Investigators

  • Susan K Raatz, PhD, RD · USDA, GFHNRC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2008-12-31
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01824498 on ClinicalTrials.gov